Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial

Elena Peeva, Emma Guttman-Yassky, Anindita Banerjee, Rodney Sinclair, Lori Ann Cox, Linda Zhu, Hua Zhu, Michael Vincent, Brett King

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)390-393
Number of pages4
JournalJournal of the American Academy of Dermatology
Issue number2
StatePublished - Aug 2022

Cite this